Many cancer patients struggle with their conditions by having negative thoughts, behaviors and emotions.
|
Researchers say the technology could one day be applied to other cancers
|
A research partnership between Michigan Medicine and Gift of Life Michigan has revealed a new pathway to understanding the progression of pancreatic cancer.
|
Novel finding suggests a possible target for improving response to immune-based cancer treatments
|
The University of Michigan Rogel Cancer Center has named Kyle Cuneo, M.D., its new associate director for clinical research. In addition, a new position of assistant director for clinical research will be filled by John Magenau, M.D. Cuneo and Magenau will collaborate with leaders across Michigan Medicine and the University of Michigan to establish processes and infrastructure in support of cancer-focused clinical research.
|
|
|
The 66th American Society of Hematology 2024 annual meeting, will be Dec. 7-10 at the San Diego Convention Center in San Diego, California, and online. University of Michigan faculty and trainees will present or moderate more than two dozen sessions and posters.
|
Clinical trials testing cancer immunotherapies significantly under-represented Black patients. So while these treatments have resulted in dramatically improved outcomes for some patients, researchers from the University of Michigan Rogel Cancer Center wanted to understand whether that success holds true for patients who are Black.
|
|
|
|
MENU